Email this article 
Changing the basic treatment as a way to achieve asthma control
- Authors: Kurbacheva OM1, Pavlova KS1
-
Affiliations:
- Institute of immunology
- Issue: Vol 12, No 2 (2015)
- Pages: 68-74
- Section: Articles
- URL: https://rusalljournal.ru/raj/article/view/470
- DOI: https://doi.org/10.36691/RJA470
- ID: 470
Cite item
Open Access
Access granted
Abstract
In the article the question of asthma control, the main reasons for its absence. The variant replacement used inhaled corticosteroids while maintaining equipotent doses as a way to achieve asthma control without increasing the pharmacologic stress.
Full Text
About the authors
O M Kurbacheva
Institute of immunology
Email: kurbacheva@gmail.com
K S Pavlova
Institute of immunology
References
- Global Initiative for Asthma (GINA Report). Global Strategy for Asthma Management and Prevention. Update 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf.
- Аллергология и иммунология: национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М., «ГЭОТАР-Медиа». 2009, 656 с.
- Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». 3-е изд., испр. и доп. М., «Атмосфера». 2008, 108 с.
- Назарова Е.В., Курбачева О.М., Ильина Н.И. Алгоритм оценки контроля бронхиальной астмы. Рос. Аллергол. Журн. 2011, № 2, с. 18-23.
- Juniper E.F., Bousquet J., Abetz L., Bateman E.D. GOAL Committee. Identifying ‘well-controlled’ and ‘not wellcontrolled’ asthma using the Asthma Control Questionnaire. Respir. Med. 2006, v. 100, p. 616-621.
- Zhou J., Liu D.F., Liu C. et al. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism. Allergy. 2008, v. 63, p. 1177-1185.
- Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус принт». 1998, 252 с.
- Derendorf H. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety. Respir. Med. 1997, v. 91, p. 22-28.
- Цой А.Н. Что определяет эффективность и безопасность применения ингаляционных ГКС в поддержании контроля над симптомами астмы. Справочник поликлинического врача. 2010, № 2, с. 37-43.
- Winkler J., Hochhaus G., Derendorf H. How the lung handles drugs. Pharmacocinetics and pharmacodinamics of inchaled corticosteroids. Proc. Am. Thorac. Soc. 2004, v. 1, p. 356-363.
- Rossi G.A., Cerasoli F., Cazzola M. Safety of inhaled corticosteroids: room for improvement. Pulmonary Pharmacology & Therapeutics. 2007, v. 20, p. 23-35.
- Maspero J.F., Nolte H., Chérrez-Ojeda I. P04139 Study Group. Long-term safety of mometasone furoate / formoterol combination for treatment of patients with persistent asthma. J. Asthma. 2010, v. 47, p. 1106-1115.
- Nathan R.A., Nolte H., Pearlman D.S. P04334 Study Investigators. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids. Allergy Asthma Proc. 2010, v. 31, p. 269-279.
- Weinstein S.F., Corren J., Murphy K. et al. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids. Allergy Asthma Proc. 2010, v. 31, p. 280-289.
- Corren J., Berkowitz R., Murray J.J., Prenner B. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Int. J. Clin. Pract. 2003, v. 57, p. 567-72.
- Nathan R.A., Nayak A.S., Graft D.F. et al. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Ann. Allergy Asthma Immunol. 2001, v. 86, p. 203-210.
Supplementary files
